CLO25-055: Metastasis-Free Survival Prediction With the 40-Gene Expression Profile Test in Patients With Cutaneous Squamous Cell Carcinoma Risk Stratified According to the National Comprehensive Cancer Network Guidelines
"CLO25-055: Metastasis-Free Survival Prediction With the 40-Gene Expression Profile Test in Patients With Cutaneous Squamous Cell Carcinoma Risk Stratified According to the National Comprehensive Cancer Network Guidelines" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- R’ay Fodor
- Shlomo A. Koyfman (ORCID: https://orcid.org/0000-0002-2275-5346)
- Brian J. Martin (ORCID: https://orcid.org/0000-0002-7243-4559)
- Allison T. Vidimos (ORCID: https://orcid.org/0000-0002-2545-7985)
- Matthew S. Goldberg (ORCID: https://orcid.org/0000-0002-5186-6491)
- Jason H. Rogers (ORCID: https://orcid.org/0000-0003-3363-8070)
- Nima M. Gharavi (ORCID: https://orcid.org/0000-0001-5870-9432)
- Emily S. Ruiz (ORCID: https://orcid.org/0000-0001-5824-2721)
- Jennifer J. Siegel (ORCID: https://orcid.org/0000-0002-5548-1716)
- Shauna R. Campbell (ORCID: https://orcid.org/0000-0002-4486-0294)
- Emily Karn
- Kelsey E. Hirotsu (ORCID: https://orcid.org/0000-0002-2595-8624)
- David Wang (ORCID: https://orcid.org/0000-0001-5597-2673)
- Karina Brito
Institutions
- Cedars-Sinai Medical Center (US)
- Brigham and Women's Hospital (US)
- Cleveland Clinic (US)
- Harvard University (US)
- Palo Alto University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7164
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00